ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
- PMID: 19168790
- PMCID: PMC2665899
- DOI: 10.1182/blood-2008-08-174813
ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
Abstract
ETS2 and ERG are transcription factors, encoded on human chromosome 21 (Hsa21), that have been implicated in human cancer. People with Down syndrome (DS), who are trisomic for Hsa21, are predisposed to acute megakaryoblastic leukemia (AMKL). DS-AMKL blasts harbor a mutation in GATA1, which leads to loss of full-length protein but expression of the GATA-1s isoform. To assess the consequences of ETS protein misexpression on megakaryopoiesis, we expressed ETS2, ERG, and the related protein FLI-1 in wild-type and Gata1 mutant murine fetal liver progenitors. These studies revealed that ETS2, ERG, and FLI-1 facilitated the expansion of megakaryocytes from wild-type, Gata1-knockdown, and Gata1s knockin progenitors, but none of the genes could overcome the differentiation block characteristic of the Gata1-knockdown megakaryocytes. Although overexpression of ETS proteins increased the proportion of CD41(+) cells generated from Gata1s-knockin progenitors, their expression led to a significant reduction in the more mature CD42 fraction. Serial replating assays revealed that overexpression of ERG or FLI-1 immortalized Gata1-knockdown and Gata1s knockin, but not wild-type, fetal liver progenitors. Immortalization was accompanied by activation of the JAK/STAT pathway, commonly seen in megakaryocytic malignancies. These findings provide evidence for synergy between alterations in GATA-1 and overexpression of ETS proteins in aberrant megakaryopoiesis.
Figures







Comment in
-
New GATA1 mutation in codon 2 leads to the earliest known premature stop codon in transient myeloproliferative disorder.Blood. 2009 Oct 22;114(17):3717-8. doi: 10.1182/blood-2009-07-233833. Blood. 2009. PMID: 19850750 No abstract available.
Similar articles
-
ERG is a megakaryocytic oncogene.Cancer Res. 2009 Jun 1;69(11):4665-73. doi: 10.1158/0008-5472.CAN-09-0075. Cancer Res. 2009. PMID: 19487285
-
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.Leukemia. 2008 Mar;22(3):521-9. doi: 10.1038/sj.leu.2405066. Epub 2007 Dec 20. Leukemia. 2008. PMID: 18094719 Free PMC article.
-
Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.Blood. 2013 Aug 8;122(6):988-98. doi: 10.1182/blood-2012-10-460998. Epub 2013 May 29. Blood. 2013. PMID: 23719302 Free PMC article.
-
GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.Adv Exp Med Biol. 2024;1459:261-287. doi: 10.1007/978-3-031-62731-6_12. Adv Exp Med Biol. 2024. PMID: 39017848 Review.
-
Transcription factor GATA-1 and Down syndrome leukemogenesis.Leuk Lymphoma. 2006 Jun;47(6):986-97. doi: 10.1080/10428190500485810. Leuk Lymphoma. 2006. PMID: 16840187 Review.
Cited by
-
Tumorigenesis in Down's syndrome: big lessons from a small chromosome.Nat Rev Cancer. 2012 Oct;12(10):721-32. doi: 10.1038/nrc3355. Epub 2012 Sep 21. Nat Rev Cancer. 2012. PMID: 22996602
-
The biology of pediatric acute megakaryoblastic leukemia.Blood. 2015 Aug 20;126(8):943-9. doi: 10.1182/blood-2015-05-567859. Epub 2015 Jul 17. Blood. 2015. PMID: 26186939 Free PMC article. Review.
-
FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells.Sci Rep. 2023 Sep 2;13(1):14454. doi: 10.1038/s41598-023-41230-1. Sci Rep. 2023. PMID: 37660196 Free PMC article.
-
Mouse models of diseases of megakaryocyte and platelet homeostasis.Mamm Genome. 2011 Aug;22(7-8):449-65. doi: 10.1007/s00335-011-9336-4. Epub 2011 Jun 11. Mamm Genome. 2011. PMID: 21667128 Review.
-
Acute Megakaryocytic Leukemia.Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034884. doi: 10.1101/cshperspect.a034884. Cold Spring Harb Perspect Med. 2020. PMID: 31548219 Free PMC article. Review.
References
-
- Holmes ML, Bartle N, Eisbacher M, Chong BH. Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1. J Biol Chem. 2002;277:48333–48341. - PubMed
-
- Gosiengfiao Y, Horvat R, Thompson A. Transcription factors GATA-1 and Fli-1 regulate human HOXA10 expression in megakaryocytic cells. DNA Cell Biol. 2007;26:577–587. - PubMed
-
- Rainis L, Toki T, Pimanda JE, et al. The proto-oncogene ERG in megakaryoblastic leukemias. Cancer Res. 2005;65:7596–7602. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases